NONALCOHOLIC FATTY LIVER DISEASE IN MENOPAUSAL WOMEN
Open Access
- 1 September 2013
- journal article
- research article
- Published by FapUNIFESP (SciELO) in Arquivos de Gastroenterologia
- Vol. 50 (3) , 180-185
Abstract
Context Nonalcoholic Fatty Liver Disease (NAFLD) is common in postmenopausal women. It is associated with metabolic syndrome. However, the influence of hormone replacement therapy in NAFLD development in these women needs to be investigated. This study aimed to describe the clinical characteristics of NAFLD in postmenopausal women, and the relationship between hormone replacement therapy and this disease. Methods From April 2009 to April 2011, 292 postmenopausal women from National Health System from Northeast of Brazil were selected, and 251 were included in this study. Menopause was defined as the absence of menstruation for 12 consecutive months in otherwise healthy women. Criteria to NAFLD included: presence of steatosis on abdominal ultrasound; history of alcohol consumption less than 20 g/day and exclusion of other liver diseases. All women underwent a clinical evaluation. Standard univariate and multivariate analyses were performed to evaluate the results. Results The mean age was 56.5 ± 6.7 years. Hormone replacement therapy was referred by 21.1% (53) women and 78.9% (198) was not. Prevalence of NAFLD was 37.1% (93/251) in postmenopausal women, 26,4% (14/53) in the group with hormone replacement therapy and 39,9% (79/198) without hormone replacement therapy. Gamma-glutamyl transpeptidase (P = 0.001), alanine transaminase (P<0.01), ferritin (P<0.001) and insulin resistance (homeostatic model assessment of insulin resistance ≥3) (P<0.001) were higher in the group of women with NAFLD diagnosis who did not referred the use of hormone replacement therapy. Metabolic syndrome was also more frequent in women with NAFLD, who did not refer hormone replacement therapy. Conclusion In conclusion this data suggests elevated prevalence of NAFLD in postmenopausal women; negative association of hormone replacement therapy and NAFLD.Keywords
This publication has 21 references indexed in Scilit:
- Aging is a risk factor of nonalcoholic fatty liver disease in premenopausal womenWorld Journal of Gastroenterology, 2012
- Early Menopause Is Associated With Lack of Response to Antiviral Therapy in Women With Chronic Hepatitis CGastroenterology, 2011
- Diagnosis of Nonalcoholic Fatty Liver Disease: Invasive versus NoninvasiveSeminars in Liver Disease, 2008
- Fatty liver disease in severe obese patients: Diagnostic value of abdominal ultrasoundWorld Journal of Gastroenterology, 2008
- Benefits of hormone replacement therapy in postmenopausal womenJournal of the American Academy of Nurse Practitioners, 2007
- Influence of age and gender in Japanese patients with non‐alcoholic steatohepatitisHepatology Research, 2007
- Protection of estrogens against the progression of chronic liver diseaseHepatology Research, 2007
- Liver fibrosis in women with chronic hepatitis C: evidence for the negative role of the menopause and steatosis and the potential benefit of hormone replacement therapyGut, 2006
- Progression of Liver Fibrosis in Women Infected With Hepatitis C: Long–Term Benefit of Estrogen ExposureHepatology, 2004
- Suppressive Effects of Estradiol on Dimethylnitrosamine–Induced Fibrosis of the Liver in RatsHepatology, 1999